FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Watson Pharmaceuticals

Watson Completes Actavis Acquisition

05-Nov-2012 - Watson Pharmaceuticals, Inc. announced that it has completed the acquisition of the Actavis Group for EUR 4.25 billion. The combination creates the world's third largest generic pharmaceutical company, with anticipated pro forma combined 2012 revenues in excess of $8 billion. Watson funded the ...

acquisitions Actavis generics

Synthon enters into global license agreement with Amgen and Watson for biosimilar trastuzumab

20-Jul-2012 - Synthon announced that it has entered into a global license agreement with Amgen Inc. and Watson Pharmaceuticals, Inc. for Synthon’s trastuzumab, being developed as a biosimilar to Herceptin®, which is currently approved for treatment of breast cancer and gastric cancer. Earlier this year Synthon ...

Amgen biosimilars breast cancer +2

Watson Names Robert A. Stewart Senior Vice President, Global Operations

18-Nov-2009 - Watson Pharmaceuticals announced that Robert A. Stewart has joined the Company in the newly created position of Senior Vice President, Global Operations, effective immediately. In this position, Mr. Stewart will have responsibility for global manufacturing, supply chain, quality and technical ...

Abbott Baxter Boehringer Ingelheim +3

Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit

30-Jul-2009 - Watson Pharmaceuticals, Inc. announced a license agreement with GeneraMedix, Inc. for the exclusive US marketing rights to a generic version of Ferrlecit (sodium ferric gluconate complex in sucrose injection), a drug indicated for the treatment of iron deficiency anemia in hemodialysis patients ...

iron deficiency license agreements Sanofi-aventis +1